imedical Overview

  • Founded
  • 2011
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

imedical General Information

Description

Provider of clinical diagnostics technology designed to improve the efficiency and mobility of imaging diagnostics. The company's clinical diagnostics technology through its software supports, manages and optimizes the entire clinical and administrative flow involved in clinical diagnostic imaging, enabling physicians to avail user friendly interface that gives them always-on access to critical patient information and workflows.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Medical Records Systems
Other Industries
Other Healthcare Services
Other Healthcare Technology Systems
Primary Office
  • Rua Do Cais Das Pedras
  • Nº8, 3º Dto
  • Porto, 4050
  • Portugal
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

imedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 02-Dec-2015 Completed Startup
3. Grant Completed Startup
2. Secondary Transaction - Private Completed Startup
1. Early Stage VC Completed Startup
To view imedical’s complete valuation and funding history, request access »

imedical Executive Team (3)

Name Title Board Seat Contact Info
Joao Guedes Co-Founder and Chief Executive Officer
Joao Paula Co-Founder & Chief Operating Officer
To view imedical’s complete executive team members history, request access »

imedical Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adventure Capital Venture Capital Minority 000 0000 000000 0
European Union Government 000 0000 000000 0
O Novo Norte Corporation 000 0000 000000 0
Pathena Venture Capital Minority 000 0000 000000 0
Portugal Ventures Venture Capital Minority 000 0000 000000 0
To view imedical’s complete investors history, request access »